Market Watch Highlights: Esperion Therapeutics Inc. (ESPR) Ends on an Upturn Note at 2.37

The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

As of close of business last night, Esperion Therapeutics Inc.’s stock clocked out at $2.37, up 11.79% from its previous closing price of $2.12. In other words, the price has increased by $11.79 from its previous closing price. On the day, 45.78 million shares were traded. ESPR stock price reached its highest trading level at $2.5254 during the session, while it also had its lowest trading level at $2.13.

Ratios:

To gain a deeper understanding of ESPR’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.87 and its Current Ratio is at 1.29.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 20 ’23 when Warren Eric sold 742 shares for $1.25 per share. The transaction valued at 924 led to the insider holds 68,318 shares of the business.

Warren Eric sold 243 shares of ESPR for $344 on Aug 18 ’23. The Chief Commercial Officer now owns 69,060 shares after completing the transaction at $1.41 per share. On Jul 19 ’23, another insider, Warren Eric, who serves as the Chief Commercial Officer of the company, sold 106 shares for $1.58 each. As a result, the insider received 168 and left with 69,303 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ESPR now has a Market Capitalization of 448880320 and an Enterprise Value of 851010752. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.47. Its current Enterprise Value per Revenue stands at 7.315 whereas that against EBITDA is -5.476.

Stock Price History:

Over the past 52 weeks, ESPR has reached a high of $3.40, while it has fallen to a 52-week low of $0.70. The 50-Day Moving Average of the stock is 1.75%, while the 200-Day Moving Average is calculated to be 31.33%.

Shares Statistics:

It appears that ESPR traded 6.08M shares on average per day over the past three months and 4457050 shares per day over the past ten days. A total of 170.42M shares are outstanding, with a floating share count of 168.54M. Insiders hold about 1.10% of the company’s shares, while institutions hold 47.88% stake in the company. Shares short for ESPR as of 1713139200 were 18601646 with a Short Ratio of 3.06, compared to 1710460800 on 17665969. Therefore, it implies a Short% of Shares Outstanding of 18601646 and a Short% of Float of 9.8500006.

Most Popular